A case of bloodstream infection caused by Ruminococcus gnavus without gastrointestinal involvement

A case of bloodstream infection caused by Ruminococcus gnavus without gastrointestinal involvement

We report a case of bloodstream infection due to Ruminococcus gnavus (R. gnavus) associated with pelvic abscess in a 74-year-old female patient undergoing radiotherapy for cervical cancer. Gram staining of positive anaerobic blood cultures revealed short chains of gram-positive cocci. Matrix-assiste...

Full description

Bibliographic Details
Main Authors:	Tomoki Furutani, Hiroyuki Kitano, Kenichiro Ikeda, Satoshi Shirane, Yumiko Koba, Seiya Kashiyama, Hiroki Kitagawa, Kohei kobatake, Keisuke Hieda, Hiroki Ohge, Nobuyuki Hinata
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Series:	Heliyon
Subjects:	Ruminococcus gnavus Bloodstream infection Piperacillin/tazobactam Gastrointestinal involvement
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023032188

Similar Items

Genetic diversity of <FONT FACE=Symbol>b</font>-glucuronidase activity among 14 strains of the dominant human gut anaerobe Ruminococcus gnavus
by: Diane Beaud, et al.
Published: (2006-01-01)

Sex-dependent Lupus Blautia (Ruminococcus) gnavus strain induction of zonulin-mediated intestinal permeability and autoimmunity
by: Gregg J. Silverman, et al.
Published: (2022-08-01)

Temperate bacteriophages infecting the mucin-degrading bacterium Ruminococcus gnavus from the human gut
by: Colin Buttimer, et al.
Published: (2023-12-01)

An Update on the Role and Potential Molecules in Relation to Ruminococcus gnavus in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus
by: Hong J, et al.
Published: (2024-03-01)

Microbial perspective of multidisciplinary collaborative weight management approach: Ruminococcus gnavus may serve as a key target for weight loss
by: Sijia Zhao, et al.
Published: (2025-12-01)

RadA, a MSCRAMM Adhesin of the Dominant Symbiote <i>Ruminococcus gnavus</i> E1, Binds Human Immunoglobulins and Intestinal Mucins
by: Marc Maresca, et al.
Published: (2021-10-01)

Mechanistic Insights Into the Cross-Feeding of Ruminococcus gnavus and Ruminococcus bromii on Host and Dietary Carbohydrates
by: Emmanuelle H. Crost, et al.
Published: (2018-11-01)

Infant early gut colonization by Lachnospiraceae: high frequency of Ruminococcus gnavus
by: Valeria eSagheddu, et al.
Published: (2016-06-01)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
by: Xueting Wang, et al.
Published: (2023-02-01)

Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysis
by: Milo Gatti, et al.
Published: (2024-12-01)

Population Pharmacokinetics of Piperacillin in Non-Critically Ill Patients with Bacteremia Caused by Enterobacteriaceae
by: Vicente Merino-Bohórquez, et al.
Published: (2021-03-01)

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
by: Cunha Ferreira T, et al.
Published: (2021-08-01)

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
by: Jihyun Yang, et al.
Published: (2023-06-01)

Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy
by: Safae Terrisse, et al.
Published: (2022-11-01)

Strains Colonizing Different Intestinal Sites within an Individual Are Derived from a Single Founder Population
by: Vadim Dubinsky, et al.
Published: (2023-02-01)

Gut microbiome and metabolome to discover pathogenic bacteria and probiotics in ankylosing spondylitis
by: Yupeng Lai, et al.
Published: (2024-04-01)

Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study
by: Ahmed M. Abdellatif, et al.
Published: (2019-11-01)

Piperacillin/Tazobactam-Induced Neutropenia: A Case Report
by: Hayati DEMİRASLAN, et al.
Published: (2012-03-01)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
by: David Busse, et al.
Published: (2021-08-01)

Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study
by: Kazutaka Oda, et al.
Published: (2021-09-01)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
by: M. Ávila-Núñez, et al.
Published: (2023-08-01)

Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
by: Yoshiki Teramoto, et al.
Published: (2023-10-01)

The association between gut microbiota development and maturation of intestinal bile acid metabolism in the first 3 y of healthy Japanese infants
by: Masaru Tanaka, et al.
Published: (2020-03-01)

Anaphylactic shock following a negative skin test for piperacillin-tazobactam: A case report
by: Lin Cheng, et al.
Published: (2024-10-01)

Impact of extended-infusion piperacillin-tazobactam in a Canadian community hospital
by: April J. Chan, et al.
Published: (2023-03-01)

Susceptive piperacillin-tazobactam-induced Evans syndrome after radical resection of esophageal cancer: A rare case report
by: Yan Li, et al.
Published: (2023-12-01)

Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
by: Daniel J. Selig, et al.
Published: (2022-05-01)

Simple HPLC-UV Method for Piperacillin/Tazobactam Assay in Human Plasma
by: Khaled Abdelkawy, et al.
Published: (2023-02-01)

Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature
by: Musa Alzahrani, et al.
Published: (2018-08-01)

The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock
by: Yang Sun, et al.
Published: (2023-06-01)

Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
by: Aafreen Bari, et al.
Published: (2022-01-01)

Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market
by: Melissa Orzechowski Xavier, et al.

Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia
by: Ryoji Kobayashi, et al.
Published: (2021-12-01)

Gpr35 shapes gut microbial ecology to modulate hepatic steatosis
by: Xin Wu, et al.
Published: (2023-03-01)

Development of a novel human intestinal model to elucidate the effect of anaerobic commensals on Escherichia coli infection
by: Conor J. McGrath, et al.
Published: (2022-04-01)

Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis
by: Claudia Saralegui, et al.
Published: (2022-12-01)

Chimeric ß-glucosidase between Cellvibrio gilvus and Ruminococcus albus enzymes
by: Truong Thi Hoa, et al.
Published: (1999-01-01)

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Namareq F. Aldardeer, et al.
Published: (2024-12-01)

Interdisciplinary Team Pilot to Reduce Time to Administration of Piperacillin/Tazobactam in the Emergency Department at a Veterans Affairs Medical Center
by: DiVittorio MM, et al.
Published: (2025-02-01)

Piperacillin/Tazobactam Co-Delivery by Micellar Ionic Conjugate Systems Carrying Pharmaceutical Anions and Encapsulated Drug
by: Katarzyna Niesyto, et al.
Published: (2024-01-01)